Patrick Page, MD
Pain Medicine · Venice, FLNPI 1770946477
Payments from drug & device makers
Across 58 payments — averaging $121.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Nevro Corp.$2K
- Medtronic$318
- Saluda Medical Americas, Inc.$167
- Johnson & Johnson$156
- plus $614 from 11 others
What the payments were for
- Speaking & faculty fees$1,18617%
- Travel & lodging$3,51450%
- Food & beverage$2,37234%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $2,491 |
| Abbott | 15 | $1,783 |
| Nevro Corp. | 4 | $1,543 |
| Medtronic | 5 | $318 |
| Saluda Medical Americas, Inc. | 2 | $167 |
| Johnson & Johnson | 2 | $156 |
| MML US, Inc. | 1 | $147 |
| GRT US Holding, Inc. | 1 | $120 |
| AbbVie | 6 | $117 |
| Acacia Pharma Inc | 1 | $54 |
| SPR Therapeutics, Inc | 1 | $52 |
| Almatica Pharma LLC | 2 | $34 |
| Edwards Lifesciences | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Globus Medical | 1 | $18 |
| Curonix LLC | 1 | $15 |
| Painteq LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion Indirect Decompression System$1,727
- Omnia$1,543
- Axium INS DRG IPG$890
- Proclaim IPG$789
- WaveWriter Alpha Prime 16$602
- ReActiv8$147
- INTELLIS$128
- PROPEL$123
- Qutenza$120
- Evoke SCS$106
How this compares
$7,072 in reported general payments places this provider in the 70th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 13 | $143 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Venice
- Anand PatelOrmond Beach$20.4M
- Julio PaezClermont$2.3M
- Joseph PergolizziNaples$2.1M
- Abel MurilloMiami$1.6M
- George MonluxPalm Coast$1.3M
- Ferdinand FormosoJacksonville$1M
- Cesar LassalleOrlando$1M
- Robert GuirguisTampa$895K
- Ashraf HannaClearwater$608K
- Peter MichaelCoral Gables$496K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.